Alfredo Carrato

20.2k total citations
343 papers, 10.0k citations indexed

About

Alfredo Carrato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Alfredo Carrato has authored 343 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Oncology, 119 papers in Pulmonary and Respiratory Medicine and 82 papers in Surgery. Recurrent topics in Alfredo Carrato's work include Colorectal Cancer Treatments and Studies (84 papers), Pancreatic and Hepatic Oncology Research (58 papers) and Gastric Cancer Management and Outcomes (52 papers). Alfredo Carrato is often cited by papers focused on Colorectal Cancer Treatments and Studies (84 papers), Pancreatic and Hepatic Oncology Research (58 papers) and Gastric Cancer Management and Outcomes (52 papers). Alfredo Carrato collaborates with scholars based in Spain, United States and Germany. Alfredo Carrato's co-authors include Núria Malats, Francisco X. Real, Manolis Kogevinas, Adonina Tardón, Cònsol Serra, Debra T. Silverman, Mustafa Dosemeci, Reina García-Closas, Nathaniel Rothman and Montserrat García‐Closas and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alfredo Carrato

335 papers receiving 9.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alfredo Carrato Spain	53	4.7k	2.9k	2.5k	2.5k	1.7k	343	10.0k
Wenqiang Wei China	40	3.6k 0.8×	3.0k 1.0×	2.7k 1.1×	3.2k 1.3×	1.8k 1.1×	187	10.1k
Mamoun Younes United States	50	2.3k 0.5×	3.1k 1.0×	1.6k 0.6×	1.9k 0.8×	2.0k 1.2×	241	9.3k
Ellen T. Chang United States	53	3.6k 0.8×	1.7k 0.6×	992 0.4×	1.3k 0.5×	1.2k 0.7×	217	10.5k
Gloria Gridley United States	67	4.1k 0.9×	2.7k 0.9×	2.2k 0.9×	3.0k 1.2×	1.5k 0.9×	161	14.2k
Mark P. Purdue United States	46	2.1k 0.4×	3.4k 1.2×	2.5k 1.0×	1.2k 0.5×	1.6k 1.0×	210	9.8k
Francisco X. Real Spain	74	5.4k 1.1×	8.0k 2.7×	1.6k 0.6×	4.8k 1.9×	2.6k 1.5×	303	16.5k
Peter Harper United Kingdom	45	4.7k 1.0×	1.4k 0.5×	3.2k 1.3×	1.9k 0.7×	867 0.5×	139	7.7k
Steinar Tretli Norway	64	4.8k 1.0×	2.6k 0.9×	1.5k 0.6×	2.5k 1.0×	2.1k 1.2×	243	11.4k
Kiyóhiko Mabuchi United States	57	2.8k 0.6×	1.7k 0.6×	3.4k 1.3×	1.5k 0.6×	1.6k 0.9×	175	15.4k
Leo J. Schouten Netherlands	54	3.1k 0.7×	1.8k 0.6×	2.6k 1.0×	2.3k 0.9×	1.2k 0.7×	228	11.2k

Countries citing papers authored by Alfredo Carrato

Since Specialization

Citations

This map shows the geographic impact of Alfredo Carrato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Carrato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Carrato more than expected).

Fields of papers citing papers by Alfredo Carrato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Carrato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Carrato. The network helps show where Alfredo Carrato may publish in the future.

Co-authorship network of co-authors of Alfredo Carrato

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Carrato. A scholar is included among the top collaborators of Alfredo Carrato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Carrato. Alfredo Carrato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hewitt, Eric W., Gauthier Bouche, Raluca Nicoleta Radu, et al.. (2025). Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients. Cancer Management and Research. Volume 17. 429–440. 1 indexed citations

Buchholz, Malte, Ludwig Lausser, Julie Earl, et al.. (2024). Combined analysis of a serum mRNA/miRNA marker signature and CA 19‐9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adenocarcinoma: A prospective multicenter cohort study. United European Gastroenterology Journal. 13(3). 353–363.

Hecht, J. Randolph, Steven S. Raman, Arlene Chan, et al.. (2023). Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases. ESMO Open. 8(2). 100884–100884. 22 indexed citations

Saavedra, Cristina, Alejandro Vallejo, Federico Longo, et al.. (2023). Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers. 15(7). 2000–2000. 1 indexed citations

Yu, Jingru, Alexander Ploner, Maximilian Kordes, et al.. (2021). Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. International Journal of Cancer. 148(8). 2048–2058. 16 indexed citations

Camps, Carlos, Rafael López‐López, Antonio Antón, et al.. (2021). Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications. JCO Oncology Practice. 17(8). e1162–e1169. 1 indexed citations

Benavides, Manuel, Auxiliadora Gómez‐España, Pilar García‐Alfonso, et al.. (2021). Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). European Journal of Surgical Oncology. 48(5). 1123–1132. 3 indexed citations

Masson-Lecomte, A., Evangelina López de Maturana, Michael E. Goddard, et al.. (2016). Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1144–1150. 4 indexed citations

Bartley, Angela N., M. Kay Washington, Christina B. Ventura, et al.. (2016). HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Archives of Pathology & Laboratory Medicine. 140(12). 1345–1363. 169 indexed citations

10.

Grande, Enrique, Jaume Capdevila, Juan J. Díez, Federico Longo, & Alfredo Carrato. (2013). A significant response to sunitinib in a patient with anaplastic thyroid carcinoma. SHILAP Revista de lepidopterología. 6 indexed citations

11.

Cutsem, Eric Van, Feng Gao, James A. Williams, et al.. (2011). ASSOCIATIONS BETWEEN GERMLINE GENOTYPE AND EFFICACY AND SAFETY OUTCOMES IN A PHASE III STUDY OF SUNITINIB AND FOLFIRI IN METASTATIC COLORECTAL CANCER (MCRC). Annals of Oncology. 22. 1 indexed citations

12.

Amaral, André F.S., Miquel Porta, Debra T. Silverman, et al.. (2011). Pancreatic cancer risk and levels of trace elements. Gut. 61(11). 1583–1588. 101 indexed citations

13.

Figueroa, Jonine D., Núria Malats, Montserrat García‐Closas, et al.. (2008). Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis. 29(10). 1955–1962. 86 indexed citations

14.

Gómez‐Martínez, Ángeles, Pilar García-Morales, Alfredo Carrato, et al.. (2007). Post-transcriptional Regulation of P-Glycoprotein Expression in Cancer Cell Lines. Molecular Cancer Research. 5(6). 641–653. 35 indexed citations

15.

Dyrskjøt, Lars, Karsten Zieger, Francisco X. Real, et al.. (2007). Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study. Clinical Cancer Research. 13(12). 3545–3551. 154 indexed citations

16.

Crous‐Bou, Marta, Miquel Porta, Tomás López‐Jiménez, et al.. (2007). Lifetime History of Tobacco Consumption and K-ras Mutations in Exocrine Pancreatic Cancer. Pancreas. 35(2). 135–141. 20 indexed citations

17.

Figueroa, Jonine D., Núria Malats, Nathaniel Rothman, et al.. (2007). Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis. 28(8). 1788–1793. 84 indexed citations

18.

López‐Knowles, Elena, Sílvia Hernández, Manolis Kogevinas, et al.. (2006). The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors. Clinical Cancer Research. 12(20). 6029–6036. 45 indexed citations

19.

López‐Knowles, Elena, Sílvia Hernández, Núria Malats, et al.. (2006). PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors. Cancer Research. 66(15). 7401–7404. 155 indexed citations

20.

Blanco, Esperanza J. Carcache de, Alfredo Carrato, Joan Maurel, et al.. (1998). Seventy-Two Hour Epirubicin Infusion Plus Quinidine in Unresectable and Metastatic Adenocarcinoma of the Pancreas. American Journal of Clinical Oncology. 21(2). 151–154. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact